Optimise trial hypertension

Author: lnmv

August undefined, 2024

WebJun 28, 2024 · The original SNAP-HT trial was designed to assess feasibility and safety of a self-management digital intervention in the postnatal period, but exploring the impact of the intervention on BP was an important secondary outcome. 25 The finding in SNAP-HT of a persistently lower diastolic BP at 6 months, when almost all women had stopped … WebOPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE) The OPTiMISE Study The aims of this study were: To safely reduce the amount of blood …

Cost-Effectiveness of Antihypertensive Deprescribing …

WebJul 7, 2024 · OPTIMISE Trial: Impact of Antihypertensive Medication Reduction in Elderly Hypertensive Patients CiplaMed Home SPECIALITY General Medicine Cardiology Critical … WebOct 5, 2024 · The researchers of this study 1 aimed to establish whether reduction of one antihypertensive medication in adults over the age of 80, on two or more antihypertensive … small ny ceramic coffe cups

Deprescribing Antihypertensive Agents in the OPTIMISE …

WebMay 12, 2024 · This study aimed to define the proportion and characteristics of patients eligible for hypertension trials conducted in older people. DESIGN: Cross-sectional study. SETTING: A total of 24... WebMar 10, 2024 · Model population characteristics were estimated using data from the OPTiMISE antihypertensive deprescribing trial, and the effects of blood pressure changes on outcomes were derived from the literature. Health-related quality of life was modeled in Quality-Adjusted Life Years (QALYs) and presented as costs per QALY gained. Results: son of rambow trailer

Blood pressure changes following antihypertensive medication …

OPtimising Treatment for MIld Systolic hypertension in the Elderly ...

WebMar 3, 2024 · Design, Setting, and Participants The Optimising Treatment for Mild Systolic Hypertension in the Elderly (OPTIMISE) study was a randomized, unblinded, noninferiority trial conducted in 69 primary ... WebMay 26, 2009 · The current study demonstrated the efficacy and safety of treating moderate or severe hypertension with triple therapy consisting of Aml/Val/HCTZ 10/320/25 mg. Initial treatment of hypertension with a dual-combination agent with complementary mechanisms of action may allow BP goals to be realized more quickly than adding single entities … son of rambow parents guideWebThe 2024 Optimizing Treatment for Mild Systolic Hypertension in the Elderly (OPTiMISE) trial examined the safety of reducing blood pressure medications in older patients with … son of ramses

"WebThe OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE) trial will target frail individuals with polypharmacy and comorbidity, and aim to establish whether a strategy of antihypertensive medication reduction is safe and acceptable to older patients. The findings of this trial will support better patient-centred ... " - Optimise trial hypertension

Optimise trial hypertension

Effects of Intensive Blood-Pressure Control in Type 2 …

WebCost-Effectiveness of Telemonitoring and Self-Monitoring of Blood Pressure for Antihypertensive Titration in Primary Care (TASMINH4) Hypertension The use of self-monitoring of blood pressure, with or without telemonitoring, to guide therapy decisions by physicians for patients with hypertension has been recently demonstrated to reduce … WebMay 28, 2024 · The OPTIMISE (Optimising Treatment for Mild Systolic Hypertension in the Elderly) study was a randomized, unblinded, noninferiority trial conducted in 69 primary …

Did you know?

WebMar 6, 2024 · As hypertension screening and management are integrated into chronic care services in sub-Saharan Africa, an opportunity exists to test whether SAIA interventions shown to be effective in improving efficiency and coverage of HIV services can be effective when applied to the non-communicable disease services that leverage the same platform. WebJul 7, 2024 · OPTIMISE Trial: Impact of Antihypertensive Medication Reduction in Elderly Hypertensive Patients CiplaMed Home SPECIALITY General Medicine Cardiology Critical Care Medicine Dermatology Dentistry Diabetology ENT Gastroenterology & Hepatology HIV / AIDS Infectious Diseases Musculoskeletal Diseases Neuropsychiatry Obstetrics & …

WebCost-effectiveness of antihypertensive deprescribing in primary care: a Markov modelling study using data from the OPTiMISE trial Sue Jowett, Shahela Kodabuckus, Gary A. Ford, F.D. Richard Hobbs, Rupert A Payne, James P. Sheppard * WebMay 26, 2024 · Design, setting, and participants: The Optimising Treatment for Mild Systolic Hypertension in the Elderly (OPTIMISE) study was a randomized, unblinded, noninferiority trial conducted in 69 primary care sites in England. Participants, whose primary care …

WebThe NIH Systolic Blood Pressure Intervention Trial (SPRINT), an NHLBI-supported study, was designed to answer three important research questions about how treating to a lower systolic blood pressure target—less than 120 millimeters of mercury (mm Hg)—affects the cardiovascular system, kidneys, and brain. WebOct 4, 2024 · The aim of this trial is to examine whether antihypertensive medication reduction is possible in older patients without significant changes in blood pressure …

WebAug 18, 2024 · 18 The rationale for OPTiMISE was that patients with frailty and multimorbidity are not well represented in previous blood pressure lowering trials and may in fact benefit from fewer treatments ...

WebMay 3, 2024 · While in the SEPSIPAM trial, patients with history of hypertension had lower incidence of severe acute kidney injury (AKI) in the higher target group, patients with history of hypertension in the 65 trial had lower 90 days mortality in the low pressure group (median MAP 65 mmHg, adjusted odds ratio, 0.67; 95% CI, 0.49–0.85). son of rambow imdbWebOct 4, 2024 · Stable dose of antihypertensive medications for at least 4 weeks prior to trial entry. In the investigator’s opinion, could potentially benefit from medication reduction … son of rambow full movieWebSep 1, 2024 · The aim of this trial is to examine whether antihypertensive medication reduction is possible in older patients without significant changes in blood pressure control at follow-up, and to determine if a reduction in medication can achieve a proportion of participants with clinically safe blood pressure levels at 12-week follow up. Introduction … small nylon bags with drawstringWebApr 1, 1998 · The aims are to (1) evaluate the relationship between three levels of target office diastolic blood pressure (BP) (≤80, ≤85, or ≤90 mm Hg) and cardiovascular morbidity and mortality in hypertensive patients and (2) examine the effects on cardiovascular morbidity and mortality of 75 mg aspirin daily versus placebo. son of rajnath singhWebOPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE) The trial is funded by the National Institute for Health Research, Oxford Collaboration for Leadership … small o27 layoutsWebOPTiMISE Optimising Treatment for Mild Systolic hypertension in the Elderly OPTiMISE Patient Information Leaflet V1.1 13.12.16_RCT.docx IRAS ID: 212465 Page 5 of 12 OPTiMISE trial – Full details What is the Purpose of the Trial? The population is getting older (over 3 million people in the UK are aged 80 son of ramses 1 crosswordWebMay 3, 2024 · While in the SEPSIPAM trial, patients with history of hypertension had lower incidence of severe acute kidney injury (AKI) in the higher target group, patients with … small nyc art gallery